Ireland
--:--IST
Starting soon Not applicable

Effect of Multimodal Physical Therapy on Vaginismus Secondary to Chronic Constipation

NCT07926399 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-11
Last updated
2026-11-09

Condition(s) studied

VaginismusChronic Constipation

Investigational drug(s) / intervention(s)

Conventional physiotherapyMultimodal physical therapy program

Conventional physiotherapy: The conventional program for vaginismus includes: 1. Massaging and stretching exercise for adductor muscles, Piriformis, low back muscles and Hamstrings. 2. Relaxation technique using diaphragmatic breathing exercise in coordination with pelvic floor muscle exercise for awareness and relaxation (contraction of pelvic floor muscles (PFM) with expiration and relaxation of PFM with deep inspiration). It will be applied for two weeks.

Multimodal physical therapy program: It will be applied for two weeks. it includes: 1. Visceral manipulation (VM) for colon release to treat constipation. 2. Progressive pelvic floor muscle relaxation technique using muscle energy techniques combined with vaginal dilators.

Study summary

The purpose of this study is to investigate the effect of multimodal physical therapy on vaginismus secondary to chronic constipation

Eligibility

Sex
FEMALE
Min age
25 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Newly married females, with regular menstrual periods, have an inability to allow vaginal penetration and failed vaginal intercourse (primary vaginismus). * They complain of chronic constipation in the form of functional obstruction due to dysfunction of pelvic floor muscle and anal sphincter (anismus), leading to difficulties in expel stool from the anorectum. * Their age ranges from 25 - 35 years old. * Their body mass index ranges from 20 - 25 Kg/m2. Exclusion Criteria: * Congenital uterine anomalies. * Pelvic or abdominal surgeries * Circumcision. * Intrinsic pelvic pathology including endometriosis, acute or chronic pelvic inflammatory disease, cervicitis, benign or malignant gynecologic tumors or uterine pathology including adenomyosis or leiomyoma and postoperative adhesions, in addition to any form of infection including herpes virus * Lesions such anorectal ulcers, inflammation or malignancy. * Irregular or infrequent menstrual cycles. * Heavy menstrual bleeding (HMB). * Systemic diseases.

Primary outcome measure(s)

  • Assessment of pain intensity — 2 weeks
    Visual analogue scale (VAS) will be used to assess pain intensity. It is a popular tool for the measurement of pain; it will be used before and after treatment. It consists of a line usually 10 cm in length, it involves a 10 cm line where the left end indicates the absence of pain, and the right end indicates unbearable pain.

Trial sites (1)

FacilityCityRegionStatus
Cairo university Cairo Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07926399 on ClinicalTrials.gov ↗ ← All trials in Egypt